136 related articles for article (PubMed ID: 20518778)
1. Seborrhoeic keratoses and acanthosis nigricans in a long-term survivor of thanatophoric dysplasia.
Nakai K; Yoneda K; Moriue T; Munehiro A; Fujita N; Moriue J; Yokoi I; Haba R; Itoh S; Kubota Y
Br J Dermatol; 2010 Sep; 163(3):656-8. PubMed ID: 20518778
[No Abstract] [Full Text] [Related]
2. [A hypothesis on the pathogeny of rounded and linear epidermal nevi (nevoid acanthosis nigricans)].
Vabres P
Ann Dermatol Venereol; 2012 Mar; 139(3):177-9. PubMed ID: 22401680
[No Abstract] [Full Text] [Related]
3. Long-term survival in typical thanatophoric dysplasia type 1.
Baker KM; Olson DS; Harding CO; Pauli RM
Am J Med Genet; 1997 Jun; 70(4):427-36. PubMed ID: 9182787
[TBL] [Abstract][Full Text] [Related]
4. FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature.
Blomberg M; Jeppesen EM; Skovby F; Benfeldt E
Dermatology; 2010; 220(4):297-305. PubMed ID: 20453470
[TBL] [Abstract][Full Text] [Related]
5. High frequency of FGFR3 mutations in adenoid seborrheic keratoses.
Hafner C; van Oers JM; Hartmann A; Landthaler M; Stoehr R; Blaszyk H; Hofstaedter F; Zwarthoff EC; Vogt T
J Invest Dermatol; 2006 Nov; 126(11):2404-7. PubMed ID: 16778799
[TBL] [Abstract][Full Text] [Related]
6. A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene.
Tavormina PL; Bellus GA; Webster MK; Bamshad MJ; Fraley AE; McIntosh I; Szabo J; Jiang W; Jabs EW; Wilcox WR; Wasmuth JJ; Donoghue DJ; Thompson LM; Francomano CA
Am J Hum Genet; 1999 Mar; 64(3):722-31. PubMed ID: 10053006
[TBL] [Abstract][Full Text] [Related]
7. Familial acanthosis nigricans due to K650T FGFR3 mutation.
Berk DR; Spector EB; Bayliss SJ
Arch Dermatol; 2007 Sep; 143(9):1153-6. PubMed ID: 17875876
[TBL] [Abstract][Full Text] [Related]
8. Type 2 segmental acanthosis nigricans: a historical case explained by a new concept.
Happle R
Arch Dermatol; 2008 Dec; 144(12):1637. PubMed ID: 19075149
[No Abstract] [Full Text] [Related]
9. Anesthetic management of an infant with thanatophoric dysplasia for suboccipital decompression.
Thompson DR; Browd SR; Sangaré Y; Rowell JC; Slimp JC; Haberkern CM
Paediatr Anaesth; 2011 Jan; 21(1):92-4. PubMed ID: 21155935
[No Abstract] [Full Text] [Related]
10. FGFR3 mutation in thanatophoric dysplasia type 1 with bilateral cystic renal dysplasia: coincidence or a new association?
Prontera P; Sensi A; Pilu G; Baldi M; Baffico M; Bonasoni R; Calzolari E
Genet Couns; 2006; 17(4):407-12. PubMed ID: 17375526
[TBL] [Abstract][Full Text] [Related]
11. Sign of Leser-Trélat.
Schwartz RA
J Am Acad Dermatol; 1996 Jul; 35(1):88-95. PubMed ID: 8682971
[TBL] [Abstract][Full Text] [Related]
12. Somatic and germline mosaicism for a R248C missense mutation in FGFR3, resulting in a skeletal dysplasia distinct from thanatophoric dysplasia.
Hyland VJ; Robertson SP; Flanagan S; Savarirayan R; Roscioli T; Masel J; Hayes M; Glass IA
Am J Med Genet A; 2003 Jul; 120A(2):157-68. PubMed ID: 12833394
[TBL] [Abstract][Full Text] [Related]
13. [Nevoid acanthosis nigricans or RAVEN (rounded and velvety epidermal nevus): three cases].
Petit A; Lemarchand-Venencie F; Pinquier L; Lebbe C; Bourrat E
Ann Dermatol Venereol; 2012 Mar; 139(3):183-8. PubMed ID: 22401682
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth receptor-3 (FGFR3) G375C mutation in a case of achondroplasia and thanatophoric dysplasia phenotypic overlap.
Barton C; Sweeney E; Roberts D; McPartland J
Clin Dysmorphol; 2010 Jul; 19(3):146-149. PubMed ID: 20357663
[No Abstract] [Full Text] [Related]
15. Development of individuals with thanatophoric dysplasia surviving beyond infancy.
Ushioda M; Sawai H; Numabe H; Nishimura G; Shibahara H
Pediatr Int; 2022 Jan; 64(1):e15007. PubMed ID: 34597445
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
[TBL] [Abstract][Full Text] [Related]
17. Malignant acanthosis nigricans with enhanced expression of fibroblast growth factor receptor 3.
Hida Y; Kubo Y; Nishio Y; Murakami S; Fukumoto D; Sayama K; Hashimoto K; Arase S
Acta Derm Venereol; 2009; 89(4):435-7. PubMed ID: 19688170
[No Abstract] [Full Text] [Related]
18. Clinical and biochemical findings of a patient with thanatophoric dysplasia type I: additional finding of dicarboxylic aciduria.
Okajima K; Asai K; Niwa T; Ohki S; Sobajima H; Tyson J; Malcolm S; Wada Y
Cleft Palate Craniofac J; 2002 Mar; 39(2):246-8. PubMed ID: 11879084
[TBL] [Abstract][Full Text] [Related]
19. FGFR3 and PIK3CA mutations in stucco keratosis and dermatosis papulosa nigra.
Hafner C; Landthaler M; Mentzel T; Vogt T
Br J Dermatol; 2010 Mar; 162(3):508-12. PubMed ID: 19845664
[TBL] [Abstract][Full Text] [Related]
20. Chylous Ascites in an Infant with Thanatophoric Dysplasia Type I with FGFR3 Mutation Surviving Five Months.
Soo-Kyeong J; Lee N; Bae MH; Han YM; Hee Park K; Byun SY
Fetal Pediatr Pathol; 2018 Oct; 37(5):363-371. PubMed ID: 30252581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
